120
2. American Academy of Pediatrics. Tetanus (lockjaw). In: Kimberlin DW, Banerjee R, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2024:848-854
3. Andreadou E, Kattoulas E, Sfagos C, et al. Stiff Person Syndrom: avoiding misdiagnosis. Neurol Sci 2007;28(1):35-37. doi:10.1007/s10072-007-0745-9
4. Buchanan N, Smit L, Cane RD, et al. Sympathetic overactivity in tetanus: fatality associated with propranolol. Br Med J. 1978;2(6132):254-255. doi:10.1136/bmj.2.6132.254-a
5. Campbell JI, Lam TM, Huynh TL, et al. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg 2009; 80(5):827-831.
6. Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 16: Tetanus. Available at: https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-16-tetanus.html (Accessed on August 11, 2025)
7. Centers for Disease Control and Prevention. Tetanus: Clinical Guidance for Wound Management to Prevent Tetanus. Available at: https://www.cdc.gov/tetanus/hcp/clinical-guidance/ (Accessed on December 6, 2025)
8. Collins S, Amirthalingam G, Beeching NJ, et al. Current epidemiology of tetanus in England, 2001-2014. Epidemiol Infect 2016; 144:3343. doi:10.1017/S095026881600128X
9. Doshi A, Warrell C, Dahdaleh D, et al. Just a graze? Cephalic tetanus presenting as a stroke mimic. Pract Neurol 2014;14(1):39-41. doi:10.1136/practneurol-2013-000541
10. Engrand N, Guerot E, Rouamba A, et al. The efficacy of intrathecal baclofen in severe tetanus. Anesthesiology. 1999;90(6):1773-1776. doi:10.1097/00000542-199906000-00036
11. Gonzales y Tucker RD, Frazee B. View from the front lines: an emergency medicine perspective on clostridial infections in injection drug users. Anaerobe 2014; 30:108. doi: 10.1016/j.anaerobe.2014.09.005
13. Johnson EA, Summanen P, Finegold SM. Clostridium. In: Manual of Clinical Microbiology, 9th edition, Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (Eds), ASM Press, Washington DC 2007. Vol 1, p.889.
14. Kyu HH, Mumford JE, Stanaway JD, et al. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017;17(1):179. doi: 10.1186/s12889-017-4111-4
15. Lalli G, Bohnert S, Deinhardt K, et al. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol. 2003;11(9):431-437. doi:10.1016/s0966-842x(03)00210-5
17. Lipman J, James MF, Erskine J, et al. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med. 1987;15(10):987-988
20. Vakil BJ, Tulpule TH, Armitage P, et al. A comparison of the value of 200,000 I.U. of tetanus antitoxin (horse) with 10,000 I.U. in the treatment of tetanus. Clin Pharmacol Ther. 1968;9(4):465-471. doi:10.1002/cpt196894465
21. World Health Organization. Module 3: Tetanus. In: The immunological basis for immunization series, World Health Organization, Geneva 2018. Available at: https://www.who.int/publications/i/item/9789241513616 (Accessed on December 6, 2025)